Woden Venture Capital (Woden) plans to acquire biotechnology company ACCUM Therapeutics Inc. for C$4.5m ($3.6m).

Both entities involved in the acquisition are based in Canada.

"German drug discovery company Evotec plans to acquire Aptuit from Welsh, Carson, Anderson & Stowe (WCAS) for $300m."

German drug discovery company Evotec plans to acquire Aptuit from Welsh, Carson, Anderson & Stowe (WCAS) for $300m.

Aptuit is a pharmaceutical services provider, while WCAS is a private equity firm. Both companies are based in the US.

The acquisition will create new business opportunities for Evotec and strengthen its market position.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Clinical Trials Arena Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Clinical Trials Arena Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now